» Articles » PMID: 22536287

Refined Qingkailing Protects MCAO Mice from Endoplasmic Reticulum Stress-Induced Apoptosis with a Broad Time Window

Overview
Date 2012 Apr 27
PMID 22536287
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

In the current study, we are investigating effect of refined QKL on ischemia-reperfusion-induced brain injury in mice. Methods. Mice were employed to induce ischemia-reperfusion injury of brain by middle cerebral artery occlusion (MCAO). RQKL solution was administered with different doses (0, 1.5, 3, and 6 mL/kg body weight) at the same time of onset of ischemia, and with the dose of 1.5 mL/kg at different time points (0, 1.5, 3, 6, and 9 h after MCAO). Neurological function and brain infarction were examined and cell apoptosis and ROS at prefrontal cortex were evaluated 24 h after MCAO, and western blot and intracellular calcium were also researched, respectively. Results. RQKL of all doses can improve neurological function and decrease brain infarction, and it performed significant effect in 0, 1.5, 3, and 6 h groups. Moreover, RQKL was able to reduce apoptotic process by reduction of caspase-3 expression, or restraint of eIF2a phosphorylation and caspase-12 activation. It was also able to reduce ROS and modulate intracellular calcium in the brain. Conclusion. RQKL can prevent ischemic-induced brain injury with a time window of 6 h, and its mechanism might be related to suppress ER stress-mediated apoptotic signaling.

Citing Articles

MicroRNA-9-3p Aggravates Cerebral Ischemia/Reperfusion Injury by Targeting Fibroblast Growth Factor 19 (FGF19) to Inactivate GSK-3β/Nrf2/ARE Signaling.

Zhou Y, Yang L, Bo C, Zhang X, Zhang J, Li Y Neuropsychiatr Dis Treat. 2021; 17:1989-2002.

PMID: 34177264 PMC: 8219303. DOI: 10.2147/NDT.S290237.


Galectin-3 protects against ischemic stroke by promoting neuro-angiogenesis via apoptosis inhibition and Akt/Caspase regulation.

Wesley U, Sutton I, Cunningham K, Jaeger J, Phan A, Hatcher J J Cereb Blood Flow Metab. 2021; 41(4):857-873.

PMID: 33736511 PMC: 7983501. DOI: 10.1177/0271678X20931137.


Cholic Acid Protects In Vitro Neurovascular Units against Oxygen and Glucose Deprivation-Induced Injury through the BDNF-TrkB Signaling Pathway.

Li C, Wang X, Yan J, Cheng F, Ma X, Chen C Oxid Med Cell Longev. 2020; 2020:1201624.

PMID: 33101581 PMC: 7576336. DOI: 10.1155/2020/1201624.


Network Pharmacology-Based Approach to Revealing Biological Mechanisms of Qingkailing Injection against IschemicStroke: Focusing on Blood-Brain Barrier.

Zhang S, Wang X, Cheng F, Ma C, Fan S, Xu W Evid Based Complement Alternat Med. 2020; 2020:2914579.

PMID: 32908557 PMC: 7474352. DOI: 10.1155/2020/2914579.


An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid.

Ma C, Wang X, Xu T, Zhang S, Liu S, Zhai C Front Pharmacol. 2020; 11:519.

PMID: 32457601 PMC: 7227481. DOI: 10.3389/fphar.2020.00519.


References
1.
David H, Haelewyn B, Rouillon C, Lecoq M, Chazalviel L, Apiou G . Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J. 2007; 22(4):1275-86. DOI: 10.1096/fj.07-9420com. View

2.
Zhang Z, Li P, Wang Z, Li P, Zhang W, Sun Z . A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury. Brain Res. 2006; 1123(1):188-95. DOI: 10.1016/j.brainres.2006.09.063. View

3.
Kumar R, Krause G, Yoshida H, Mori K, DeGracia D . Dysfunction of the unfolded protein response during global brain ischemia and reperfusion. J Cereb Blood Flow Metab. 2003; 23(4):462-71. DOI: 10.1097/01.WCB.0000056064.25434.CA. View

4.
Fisher M, Hanley D, Howard G, Jauch E, Warach S . Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes. Stroke. 2007; 38(2):245-8. DOI: 10.1161/01.STR.0000255951.37434.aa. View

5.
Hao Y, Kong X, Wu T . Assessment of the safety of Qin Kai Ling injection: a systematic review. J Evid Based Med. 2011; 3(2):105-16. DOI: 10.1111/j.1756-5391.2010.01074.x. View